Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18931,130,1.20 [0.79-1.81],0.387123413402981
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19752,150,0.90 [0.56-1.43],0.6481284266756238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19543,1129,1.03 [0.88-1.21],0.697317009342842
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19759,290,1.13 [0.85-1.52],0.3903362115266886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19175,2796,1.02 [0.92-1.13],0.715611366162642
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19165,2817,1.05 [0.95-1.15],0.3717707126525883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19583,852,1.05 [0.87-1.25],0.6287485445488741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19704,66,0.46 [0.20-1.07],0.072696536273281
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17947,880,0.99 [0.82-1.18],0.8717464751968049
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17308,963,1.07 [0.91-1.26],0.4162446481694448
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17124,192,1.16 [0.82-1.65],0.3871088166676701
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13883,1822,1.04 [0.92-1.17],0.5720528245423369
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17069,326,1.20 [0.93-1.56],0.1641822814852707
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19752,1021,1.06 [0.90-1.25],0.4861690234758111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19831,362,1.14 [0.88-1.48],0.3061017858753928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19124,710,0.96 [0.78-1.18],0.6869166847650205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19770,969,1.04 [0.88-1.23],0.6433461547960654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18883,152,0.89 [0.56-1.41],0.6110308439572838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19864,40,1.04 [0.46-2.36],0.922388131502756
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19646,845,0.98 [0.82-1.18],0.8506918520194584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19689,51,1.13 [0.55-2.29],0.7449496551772175
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19808,97,1.18 [0.72-1.92],0.508875485819184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19794,83,1.07 [0.61-1.88],0.8116295213074354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18803,389,1.02 [0.78-1.33],0.8905314351935938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18646,232,1.15 [0.83-1.58],0.4122722625530584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18800,69,1.28 [0.74-2.21],0.3807477549905422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19846,56,1.30 [0.72-2.36],0.3886517192372916
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19816,124,1.08 [0.69-1.70],0.7214290644892372
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,19738,46,1.25 [0.65-2.40],0.4994506795138582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19737,45,1.11 [0.54-2.29],0.7811309669385158
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19605,289,1.04 [0.77-1.41],0.7995581101668776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19806,41,1.12 [0.52-2.43],0.773551609961423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19774,49,0.33 [0.12-0.92],0.0335986661862156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19825,107,1.24 [0.80-1.91],0.3388072017853484
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19553,1363,1.03 [0.89-1.18],0.7056275445234051
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,19863,25,1.04 [0.37-2.98],0.9357791136242528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19814,56,1.27 [0.69-2.34],0.4438452911733488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19852,65,1.57 [0.98-2.49],0.0579948547193386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19842,380,1.13 [0.87-1.45],0.3541456907189686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,19844,287,1.24 [0.95-1.63],0.1110887214628798
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19755,62,1.45 [0.87-2.43],0.1556482091995335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19840,241,0.97 [0.68-1.37],0.8499831563903757
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19803,347,0.77 [0.56-1.07],0.1157855526739654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19761,617,1.11 [0.91-1.36],0.2954582932558671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19830,460,1.15 [0.92-1.44],0.2298484322393212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15485,61,0.65 [0.40-1.06],0.0828214097677231
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15482,58,0.79 [0.37-1.70],0.5440329993945704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19837,79,0.97 [0.53-1.78],0.9187643779804628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",19837,76,0.97 [0.52-1.80],0.9181997705438592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,13247,297,0.94 [0.68-1.30],0.6987657768516641
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lymphoid leukaemia,15480,56,0.61 [0.26-1.43],0.2504332258270715
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15585,161,1.06 [0.72-1.56],0.7611004147663066
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15662,238,0.81 [0.55-1.18],0.2681331686704902
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15500,76,0.84 [0.43-1.63],0.6060770649121143
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15530,106,0.82 [0.47-1.44],0.4969794035064037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15545,121,1.02 [0.64-1.64],0.9211031948461884
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15494,70,1.23 [0.72-2.11],0.4434802628932481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16567,1143,0.85 [0.72-1.01],0.0665761661806171
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15551,127,0.99 [0.62-1.58],0.9617111362225534
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15513,89,0.97 [0.55-1.72],0.9277832810455268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15526,102,1.05 [0.65-1.72],0.8319094268413975
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,19766,145,0.82 [0.50-1.32],0.4102949676421886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,19838,85,0.60 [0.30-1.21],0.1541714215703834
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanoma in situ,15452,62,0.75 [0.35-1.59],0.4532436612089008
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15509,85,0.67 [0.34-1.32],0.2511642862505437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15563,139,0.64 [0.38-1.10],0.1084621979555277
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15616,192,0.78 [0.50-1.20],0.2613574908722369
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15510,86,0.58 [0.29-1.16],0.1232722321013167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,19753,123,1.09 [0.69-1.73],0.7042833309368379
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16411,987,0.92 [0.77-1.09],0.3241149946470625
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16472,1048,0.98 [0.84-1.15],0.8276590009779207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19636,243,1.05 [0.75-1.46],0.7930443455349474
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18462,63,1.37 [0.79-2.39],0.2631689999247567
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19450,57,0.81 [0.37-1.77],0.5958268372590436
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19434,2247,1.01 [0.90-1.13],0.8680496142876611
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18854,51,1.53 [0.88-2.64],0.1318185721081308
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19517,42,1.13 [0.53-2.42],0.7461475790377481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19590,1191,1.08 [0.93-1.25],0.3402313095457043
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19588,1189,1.07 [0.93-1.25],0.3441325667127984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18476,77,1.24 [0.73-2.09],0.4290571641066777
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19679,876,1.09 [0.92-1.29],0.3242618561245137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19564,89,1.01 [0.58-1.77],0.9759479720952264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19453,60,1.62 [1.01-2.58],0.0442612847136599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19448,55,0.65 [0.41-1.03],0.0660369603304039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19728,253,1.14 [0.84-1.55],0.4140252431882922
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19783,38,1.39 [0.70-2.78],0.3484308956508271
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19682,207,1.27 [0.93-1.73],0.1310196674381597
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18862,59,0.69 [0.30-1.58],0.3780888968885725
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14719,301,1.12 [0.84-1.49],0.4551157879300586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18154,136,0.91 [0.57-1.46],0.7075505668627675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18175,157,1.22 [0.84-1.75],0.2936230186972809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14466,48,1.99 [1.32-2.98],0.0009263222342392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18748,53,0.35 [0.13-0.93],0.0360588899098447
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18129,177,1.15 [0.79-1.67],0.4706876482714761
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19484,471,0.96 [0.74-1.23],0.7316321855068577
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19205,192,0.98 [0.67-1.43],0.903614775970993
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19127,114,0.92 [0.55-1.54],0.7479669357373706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19614,919,1.02 [0.85-1.21],0.8596731743167236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17026,887,1.04 [0.87-1.23],0.6682605423837527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14479,61,0.67 [0.30-1.50],0.3314705444242928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19171,36,1.60 [0.87-2.95],0.1322441258404637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14635,217,0.87 [0.59-1.29],0.4972356334897415
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14479,61,1.02 [0.53-1.98],0.9471739384243644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17619,3201,1.02 [0.93-1.12],0.6198038560564856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14571,153,1.15 [0.78-1.72],0.4761337449439714
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,14876,458,0.95 [0.73-1.22],0.6784134611862058
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19818,218,0.92 [0.63-1.34],0.6632629981863205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19666,66,0.66 [0.30-1.44],0.2925657770651927
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14543,125,0.98 [0.60-1.58],0.9196313690524518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14471,53,1.58 [0.97-2.57],0.0634843662467576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19713,578,1.04 [0.84-1.29],0.7222866577423434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14654,236,1.04 [0.74-1.46],0.8278589983375964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14696,278,0.95 [0.68-1.32],0.7501581517622008
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15014,596,1.09 [0.89-1.34],0.4020204690489759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14531,113,1.34 [0.90-2.01],0.1530151806773444
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19661,61,0.69 [0.31-1.54],0.3683023850431719
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14895,477,1.07 [0.85-1.36],0.5485141277715434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14743,325,0.95 [0.70-1.29],0.7440776749400297
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17997,45,0.97 [0.43-2.19],0.9426253184424402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18717,4299,1.02 [0.94-1.10],0.6838614103214855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19146,11,0.71 [0.11-4.73],0.726728154593717
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19155,20,1.33 [0.48-3.72],0.5811067761032209
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19728,1451,1.16 [1.02-1.33],0.0260885796055562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19724,1446,1.17 [1.02-1.34],0.0214975993672706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19146,11,1.93 [0.70-5.27],0.2013380014163818
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19639,674,0.90 [0.73-1.12],0.3589835601497915
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15729,1311,0.99 [0.86-1.15],0.9215612974499432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19856,195,1.14 [0.80-1.63],0.4533993742082207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19095,82,0.83 [0.43-1.58],0.5623108523002205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19027,62,1.12 [0.60-2.10],0.7207460294620367
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19039,74,1.30 [0.78-2.15],0.3158848200529349
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14472,54,0.83 [0.38-1.81],0.6413354489241522
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17535,137,1.08 [0.70-1.68],0.7202067203032712
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2105,101,1.37 [0.87-2.14],0.172407879874341
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2242,265,1.13 [0.80-1.59],0.4893840688454522
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17476,78,0.68 [0.33-1.37],0.2803348440338506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2060,56,1.26 [0.64-2.46],0.5068411925917445
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19234,1836,1.05 [0.93-1.19],0.4310240398736614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19279,266,1.18 [0.89-1.57],0.2610011875072427
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18147,195,1.35 [0.98-1.86],0.0703199137780203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15037,619,1.06 [0.87-1.31],0.5586669109945581
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19755,201,1.08 [0.76-1.54],0.6686693225512406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18868,231,1.27 [0.93-1.74],0.1360847908898191
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17475,1223,1.09 [0.95-1.26],0.2204348546205446
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18963,326,1.05 [0.78-1.41],0.7402676229458832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18702,65,1.59 [1.00-2.54],0.052159140367834
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18825,188,1.36 [0.99-1.88],0.0583073998379864
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11632,1869,0.96 [0.85-1.08],0.4697768774666698
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,AV-block,16066,498,0.83 [0.64-1.07],0.1459189161737216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19805,429,0.94 [0.72-1.22],0.644446054771193
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9968,205,0.68 [0.44-1.05],0.0832094195699808
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15733,165,0.93 [0.61-1.42],0.7337178172840635
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15656,88,1.27 [0.79-2.04],0.3277064387400492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19865,48,1.32 [0.70-2.49],0.3829218012455823
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,16679,1111,0.98 [0.84-1.15],0.7912622313674323
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18401,2168,1.05 [0.94-1.17],0.4314251447334511
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16814,6487,1.02 [0.96-1.09],0.4844147131147683
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18846,220,1.10 [0.78-1.54],0.5959093662761155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,15638,70,0.44 [0.19-1.00],0.0504277042765594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19601,1081,1.01 [0.86-1.19],0.8731468764585185
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,17803,5646,1.03 [0.96-1.10],0.4016769634892353
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17809,5652,1.03 [0.96-1.10],0.3905082073077905
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19675,97,1.22 [0.76-1.95],0.4139058418946558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12321,164,1.18 [0.83-1.69],0.3613954930682864
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12249,92,0.88 [0.49-1.58],0.6646179039664625
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,19745,971,1.08 [0.92-1.27],0.3681356489226249
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18998,95,0.82 [0.45-1.50],0.5193669256501194
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18511,2259,1.05 [0.94-1.17],0.3716699855172382
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19528,539,1.19 [0.97-1.47],0.0916876396183761
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15910,342,1.25 [0.99-1.59],0.0610174815210704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19278,885,0.97 [0.81-1.16],0.7472672569035692
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17016,764,0.92 [0.75-1.13],0.447787107622445
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19728,187,0.91 [0.60-1.38],0.6518582591256675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19821,316,0.98 [0.73-1.33],0.9178581643358188
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18682,56,0.92 [0.43-1.95],0.8259568113834442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,18708,71,1.00 [0.52-1.91],0.9980135286356828
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15971,403,1.08 [0.85-1.38],0.5305136990550359
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18744,107,1.49 [1.01-2.20],0.0459625438938806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18862,225,1.50 [1.15-1.94],0.0026759485277058
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15718,150,0.97 [0.63-1.50],0.9084649141807036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18698,72,1.06 [0.57-1.98],0.8452259317512771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18667,41,1.13 [0.51-2.50],0.7624324201339487
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18570,75,0.95 [0.51-1.79],0.8837712020961106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18712,86,1.63 [1.09-2.43],0.0162531607491391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16586,1018,1.07 [0.92-1.25],0.3959153333310252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18827,53,0.67 [0.28-1.61],0.375573093899335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19093,456,1.33 [1.08-1.64],0.0080462031390218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19329,307,1.21 [0.92-1.58],0.1731041519537892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19035,540,1.36 [1.13-1.63],0.0010950832811713
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10068,305,1.02 [0.76-1.36],0.9097696395582416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19012,415,1.08 [0.83-1.39],0.5772536618520985
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18911,285,1.14 [0.85-1.52],0.3743708918668974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19428,406,1.19 [0.94-1.50],0.1524712391947052
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19812,576,1.06 [0.86-1.31],0.5948025692527503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15960,392,0.84 [0.63-1.11],0.2211884361050851
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19328,306,1.21 [0.92-1.59],0.170772875201021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18674,179,1.18 [0.82-1.70],0.3591153392060608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19515,612,1.12 [0.91-1.37],0.2849543469761662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19504,637,1.11 [0.91-1.35],0.315666515876073
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18983,39,0.79 [0.30-2.05],0.6240448521296356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18732,96,1.06 [0.62-1.80],0.8276470835769294
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19183,194,1.45 [1.08-1.94],0.012866116605473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18653,260,1.04 [0.75-1.43],0.8327576803786941
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,18939,313,1.27 [0.98-1.64],0.067965815825161
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18653,61,1.28 [0.71-2.31],0.4048041758307233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19655,633,1.14 [0.94-1.38],0.1794671267252775
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19692,405,1.16 [0.91-1.48],0.224848779925111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17120,815,0.93 [0.77-1.13],0.48753909578651
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,19284,2979,1.01 [0.91-1.11],0.9150553274916586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19639,474,1.13 [0.90-1.42],0.297421556002392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17259,954,0.99 [0.84-1.18],0.9417550126884884
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16369,64,0.56 [0.24-1.29],0.1727784345342439
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,19312,1287,1.13 [0.97-1.32],0.1136527188553186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17856,1551,1.07 [0.93-1.23],0.3450720949339808
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,19486,118,0.97 [0.59-1.60],0.9108549366007068
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,19864,242,1.07 [0.78-1.48],0.680169287295483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13287,46,1.09 [0.51-2.34],0.8264666362572248
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,18725,67,1.03 [0.54-1.96],0.9261768048858148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18948,290,0.94 [0.68-1.29],0.6884017993958378
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19534,195,1.04 [0.72-1.51],0.8348083451789244
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19790,275,0.98 [0.70-1.35],0.8855829914868687
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19463,55,1.13 [0.58-2.16],0.7236459718383708
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19849,66,1.42 [0.86-2.35],0.1740784772614094
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19415,76,1.64 [1.09-2.46],0.0176229306586268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,18539,228,1.11 [0.79-1.55],0.5477114961193309
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19428,1117,1.16 [1.01-1.34],0.0423976028000523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19832,392,1.03 [0.79-1.33],0.8343381244206072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19406,1760,1.08 [0.96-1.22],0.1924393970306656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19551,48,1.50 [0.84-2.68],0.1680288911883697
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,19729,214,1.05 [0.74-1.50],0.7912187436601533
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,19387,48,1.10 [0.53-2.26],0.796895688546487
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19848,49,0.94 [0.43-2.08],0.8850450332215481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18678,20,0.56 [0.13-2.42],0.4368763499342653
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18737,79,1.01 [0.55-1.83],0.9793931771606788
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Memory loss,19353,102,1.27 [0.82-1.97],0.2751375085444928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,18472,161,1.16 [0.79-1.70],0.4582819212506098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19844,146,0.97 [0.62-1.52],0.8964920929335243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,13390,137,1.11 [0.73-1.70],0.6225100501619514
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19765,57,1.34 [0.75-2.42],0.3262563631103602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19465,807,1.09 [0.92-1.31],0.3218716415311394
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,18761,2927,1.12 [1.02-1.23],0.0132603160828866
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19589,181,1.04 [0.71-1.53],0.8453399457496746
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18962,304,1.24 [0.95-1.61],0.1143339120874967
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19790,287,1.22 [0.92-1.60],0.1667157384854972
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15687,504,1.15 [0.93-1.44],0.1975718701721072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19402,63,0.94 [0.47-1.89],0.8664823289242897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19462,123,1.04 [0.65-1.66],0.8781057270527409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19549,109,0.98 [0.59-1.64],0.9495341005826602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18742,84,0.95 [0.52-1.73],0.8571224741696584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18344,33,0.78 [0.28-2.22],0.644003194273379
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19767,428,1.07 [0.84-1.37],0.586983964120835
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18889,578,1.10 [0.89-1.36],0.3888284102689217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,19843,264,1.08 [0.80-1.46],0.6305313527848637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19361,22,0.36 [0.08-1.65],0.1898249896497374
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19863,35,0.46 [0.14-1.49],0.1942563076594035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19622,524,1.16 [0.93-1.44],0.1785930051620957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19550,47,1.02 [0.48-2.18],0.9512931120806192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19847,157,1.05 [0.70-1.58],0.8223689122171838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18686,28,0.97 [0.35-2.69],0.9500070562202394
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19864,245,1.07 [0.78-1.47],0.6761883307959901
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19459,114,0.98 [0.60-1.63],0.9505887730836372
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19421,67,0.91 [0.46-1.79],0.778030405949457
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19578,240,1.11 [0.81-1.53],0.5193513581769769
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19714,246,1.00 [0.71-1.41],0.9883915548385056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19132,34,0.51 [0.16-1.61],0.2480475445663016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19150,52,1.52 [0.87-2.66],0.1378770001473356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19790,35,0.80 [0.29-2.19],0.6596963422601954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19676,102,0.91 [0.52-1.58],0.731435816641968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2060,56,1.24 [0.63-2.45],0.5274130172249096
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2511,106,1.32 [0.87-2.01],0.1919859453982388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19434,80,0.65 [0.32-1.33],0.2352610646976599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19673,825,1.01 [0.84-1.22],0.8957583607112976
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19601,503,1.09 [0.87-1.37],0.4332804591709412
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19213,115,0.94 [0.56-1.57],0.8060154912650229
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19803,465,1.03 [0.81-1.31],0.8277191601806736
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19862,54,0.56 [0.23-1.39],0.2135633206296331
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19751,413,1.02 [0.79-1.31],0.8961404785636536
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19834,260,0.96 [0.68-1.34],0.8046394176621592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19790,124,0.79 [0.46-1.35],0.3894701297040481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19162,64,1.41 [0.85-2.34],0.1888384183869534
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19169,71,1.41 [0.86-2.32],0.1716775301018822
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19132,34,1.11 [0.47-2.62],0.8152650344944371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19787,571,1.07 [0.87-1.32],0.5253901855969683
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19380,164,1.09 [0.74-1.60],0.6788734903147817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19360,22,0.90 [0.28-2.93],0.8620124015685394
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19654,80,1.08 [0.61-1.92],0.7808705147376049
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19758,184,0.92 [0.61-1.38],0.6858503608023789
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19485,147,0.83 [0.52-1.34],0.4566201534953776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19733,67,1.00 [0.53-1.89],0.9987583475928732
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19586,370,0.98 [0.74-1.30],0.905389089080919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19449,95,1.18 [0.72-1.93],0.5178311368849334
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18753,1476,1.09 [0.95-1.24],0.2201683462726189
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19734,160,0.91 [0.58-1.41],0.6601684715576197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19849,117,0.80 [0.46-1.39],0.4333122405059114
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19443,345,1.20 [0.93-1.55],0.1520422574557391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19631,57,0.88 [0.41-1.88],0.7365136883802416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19852,44,0.72 [0.28-1.83],0.4894552706738261
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19159,61,0.90 [0.44-1.85],0.7793913081247925
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19222,124,1.05 [0.66-1.67],0.8302240000693806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18952,104,0.81 [0.45-1.45],0.4756201603340002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19375,37,1.29 [0.64-2.62],0.4795841190962608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18898,50,0.96 [0.46-2.01],0.9104808243631916
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19259,43,0.65 [0.25-1.71],0.3834819891567217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19384,168,1.34 [0.96-1.87],0.0823003947374538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19186,88,1.08 [0.63-1.87],0.7792066952543939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18949,101,0.86 [0.49-1.51],0.5921264289260827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18925,77,1.56 [1.02-2.39],0.0392625157481527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18466,1189,0.83 [0.70-0.99],0.0338461261882873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19144,46,1.34 [0.70-2.54],0.3772070384575307
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19662,308,0.93 [0.68-1.28],0.6528063325000706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19410,56,1.02 [0.50-2.09],0.946822214081134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19476,122,1.20 [0.79-1.83],0.3889888693666093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19710,50,1.31 [0.71-2.41],0.3801765794011269
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19828,104,0.97 [0.57-1.65],0.9010993474317214
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19751,95,0.95 [0.54-1.67],0.8617157487141978
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19704,44,0.63 [0.24-1.66],0.3517127086730065
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19706,46,1.21 [0.61-2.39],0.5809043724434272
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19780,764,1.01 [0.84-1.23],0.8798751453702054
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19587,571,0.99 [0.80-1.24],0.9437804413801022
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19123,107,1.04 [0.63-1.72],0.867842141879008
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19082,66,1.21 [0.68-2.16],0.5088768671299968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19686,46,0.49 [0.18-1.35],0.167436831135572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19794,154,0.64 [0.38-1.08],0.0915342198006293
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19690,50,0.59 [0.23-1.49],0.2628296823951657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza,18019,83,0.71 [0.36-1.41],0.3285466789113799
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18016,80,0.71 [0.35-1.43],0.3364966337726106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13037,87,1.36 [0.85-2.16],0.2000811764093977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19777,228,0.80 [0.54-1.19],0.2726203210167182
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13861,1197,1.12 [0.97-1.29],0.1331417671839644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14126,1176,1.12 [0.97-1.29],0.1370449444809238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19538,119,0.94 [0.57-1.55],0.7993927041303999
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18008,72,1.00 [0.53-1.88],0.998626970887483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,17253,238,1.02 [0.72-1.43],0.9297630573472628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17051,36,0.92 [0.36-2.39],0.8671652062383373
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19144,2129,1.10 [0.99-1.23],0.0775994592876773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18648,68,0.81 [0.40-1.65],0.5573865155373513
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18711,131,1.36 [0.93-1.98],0.1125178254139849
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19680,1080,1.06 [0.91-1.25],0.4440894188932337
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18705,125,0.74 [0.43-1.29],0.2859328758651142
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18173,4350,1.07 [0.99-1.15],0.1022024924360698
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18913,333,0.74 [0.53-1.04],0.0857473590901387
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,18865,265,1.18 [0.87-1.60],0.2990547718273125
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Emphysema,17313,298,1.27 [0.96-1.68],0.0979201106621201
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19072,295,1.13 [0.85-1.51],0.4002965971262242
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19655,1719,1.03 [0.91-1.17],0.6581118842618926
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,19092,315,1.10 [0.82-1.47],0.5188962557064061
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,18949,815,1.03 [0.85-1.24],0.7794295954733252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19848,324,1.04 [0.78-1.39],0.7775730159876195
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,18708,128,1.04 [0.66-1.65],0.8555395531940984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19632,796,1.09 [0.92-1.31],0.3231319388180905
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19630,1818,1.03 [0.91-1.16],0.6729182847447506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19316,736,0.85 [0.69-1.06],0.1506825062966071
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,17861,49,1.54 [0.91-2.63],0.1101248566907768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19770,387,1.03 [0.79-1.34],0.8515967709244576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19759,1154,0.97 [0.82-1.14],0.6881752289347356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,18726,914,1.07 [0.90-1.26],0.4596685484518618
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,18034,222,0.98 [0.69-1.41],0.9209696785314844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19443,1507,1.03 [0.90-1.18],0.6940115800551587
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19762,238,1.15 [0.84-1.57],0.3930086848793329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,17931,119,0.75 [0.43-1.31],0.3049285572552205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,19849,195,0.70 [0.45-1.10],0.1192952160737346
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19441,58,0.98 [0.48-1.99],0.9456071772910828
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12995,45,0.74 [0.29-1.91],0.5310393483262361
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19617,781,1.06 [0.89-1.28],0.5149027155084358
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18809,229,0.79 [0.53-1.17],0.2354324256670311
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,18163,227,1.21 [0.88-1.66],0.2358785979545036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19558,193,1.16 [0.82-1.64],0.4108922854969163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8714,90,0.80 [0.43-1.48],0.4733434333476606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13909,73,1.26 [0.74-2.15],0.3878928621548145
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19754,122,1.13 [0.73-1.77],0.5790785624377883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,15056,70,0.87 [0.44-1.75],0.7016336234421156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18735,172,0.76 [0.48-1.20],0.243277468202579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19567,77,1.15 [0.66-1.99],0.6180570595162664
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19103,91,1.59 [1.09-2.33],0.0156394863803415
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,15413,427,1.14 [0.90-1.45],0.270723909235486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18665,102,1.06 [0.64-1.74],0.8238514651448309
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19519,102,1.06 [0.64-1.76],0.8206236970994614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,18742,179,0.99 [0.66-1.47],0.9514293418031275
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,19224,661,0.95 [0.77-1.18],0.6507551457796574
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,15198,212,1.16 [0.83-1.63],0.3824687331703238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18612,49,0.85 [0.37-1.96],0.6963163805367758
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19693,115,1.17 [0.75-1.83],0.4935750444580875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,18489,72,1.19 [0.68-2.08],0.5433463588126524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18661,41,1.22 [0.59-2.53],0.5860246769621819
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19717,185,1.17 [0.81-1.68],0.4092284479481897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,19733,1270,1.00 [0.86-1.16],0.9972911419148908
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,18697,77,1.12 [0.63-1.98],0.6978879368154101
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19570,56,1.05 [0.53-2.10],0.8843886147993464
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18685,65,1.39 [0.83-2.34],0.2153259864881955
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,19327,184,1.41 [1.03-1.92],0.0317549641774628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16855,1596,1.08 [0.95-1.22],0.2562785602732933
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19780,148,1.21 [0.82-1.78],0.344014791642155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,19748,736,1.03 [0.85-1.26],0.7293000336742922
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18191,3205,1.00 [0.91-1.10],0.9976449026791776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19558,415,1.32 [1.06-1.65],0.011747771295037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19825,335,1.12 [0.86-1.47],0.401059882384675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19232,89,1.24 [0.75-2.04],0.3998033282476075
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19121,51,1.27 [0.67-2.42],0.4697512314065002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19601,1184,1.13 [0.98-1.30],0.0991779225721318
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,19132,95,1.77 [1.27-2.47],0.000733122921283
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19565,1002,0.93 [0.79-1.11],0.4441478724104938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16392,2556,1.01 [0.91-1.12],0.8257600258019338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15199,213,0.86 [0.57-1.28],0.4452603747090341
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19765,165,0.91 [0.59-1.41],0.6730471318664537
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19804,35,0.93 [0.36-2.40],0.8821010710592226
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19146,134,1.10 [0.72-1.69],0.6558129624492596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,13985,149,1.29 [0.90-1.87],0.1682888679411455
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15334,348,1.01 [0.76-1.35],0.9223464315627612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,15295,309,1.06 [0.79-1.44],0.695280656054347
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16752,1766,1.02 [0.90-1.15],0.7910141440778666
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15476,490,0.92 [0.71-1.19],0.5293756961747398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15186,6621,1.02 [0.95-1.08],0.6198614885623497
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,19395,978,1.16 [1.00-1.36],0.0572667073037127
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19185,42,1.54 [0.86-2.76],0.1468983289762606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14604,998,1.03 [0.87-1.21],0.7562051695805392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19082,70,1.43 [0.87-2.34],0.1568120617930647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,18165,2906,1.01 [0.92-1.11],0.8548530496991895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,19807,34,0.95 [0.37-2.46],0.9139715422731431
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,13870,34,0.90 [0.35-2.34],0.8336049614226293
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,16618,1359,0.96 [0.83-1.11],0.5460122270619958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15418,159,1.15 [0.79-1.67],0.4705904068167733
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,13912,76,1.31 [0.80-2.16],0.2823954452923961
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18501,84,1.29 [0.79-2.09],0.3102524241358741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14075,239,0.95 [0.67-1.35],0.7712732347404407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19827,314,1.01 [0.74-1.36],0.968730525226528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19177,557,0.95 [0.75-1.20],0.6514968333961857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19355,735,1.02 [0.84-1.24],0.8245650829290863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15162,176,1.04 [0.70-1.54],0.8567211590802554
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,15509,523,1.04 [0.83-1.31],0.7339766712391935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19816,90,1.14 [0.68-1.90],0.6245127918877148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15321,62,0.83 [0.40-1.71],0.6078483532999691
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15043,1207,1.06 [0.92-1.23],0.4116205011677897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18779,216,0.94 [0.65-1.36],0.7271113173018272
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18664,101,1.11 [0.68-1.80],0.6737312792830743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,15407,1571,1.09 [0.96-1.24],0.1794577179311604
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18346,4510,1.04 [0.96-1.12],0.3221438740439196
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19102,148,1.15 [0.78-1.71],0.4742938799560192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19599,587,0.99 [0.79-1.23],0.9170936297371004
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15586,600,1.12 [0.91-1.38],0.2685254601248156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18678,115,1.04 [0.65-1.69],0.8619552127225784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19772,282,1.15 [0.86-1.53],0.347804267541218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15643,657,1.02 [0.83-1.25],0.8491808762679013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19404,987,1.16 [0.99-1.35],0.0590782195478344
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19286,143,1.20 [0.80-1.79],0.3791814161538295
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15136,1300,1.06 [0.92-1.22],0.3880003176597376
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16518,1532,1.00 [0.87-1.15],0.963596280783048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19091,79,1.19 [0.70-2.04],0.5180656886000238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19260,640,0.98 [0.80-1.22],0.8884256852169145
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14121,285,1.28 [0.98-1.66],0.0676390181922821
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19795,43,0.85 [0.35-2.07],0.7169128136161259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14227,391,1.20 [0.95-1.52],0.1274599269378484
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18561,144,1.08 [0.71-1.66],0.7112246229572594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19851,34,0.45 [0.14-1.49],0.1920630184197965
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19149,84,0.70 [0.36-1.38],0.3072278143461231
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,18656,36,1.27 [0.61-2.67],0.5241203550121067
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15237,251,0.98 [0.70-1.38],0.9208848513980366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18746,126,1.00 [0.62-1.61],0.9964165517984426
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18725,105,1.09 [0.67-1.79],0.7302331351315454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15553,294,0.85 [0.61-1.19],0.3423476074007603
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13967,131,0.82 [0.49-1.36],0.4413721241211849
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,15472,213,1.29 [0.95-1.74],0.1035819484410943
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Volvulus,13896,60,1.15 [0.62-2.14],0.6619037786686532
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19811,262,0.95 [0.68-1.32],0.7503818386299
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19609,60,0.92 [0.45-1.89],0.8167563695977409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18236,80,0.72 [0.36-1.42],0.3450606110715313
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19249,625,0.96 [0.77-1.19],0.6954337249431005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18792,168,0.77 [0.48-1.24],0.2854014403325204
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18518,362,1.06 [0.81-1.39],0.6574776827373814
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19621,218,0.78 [0.52-1.17],0.2228231219442375
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19785,382,0.85 [0.63-1.14],0.280028445051146
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19440,37,1.05 [0.46-2.41],0.9090381489413498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18613,2597,0.98 [0.88-1.09],0.7431220102827418
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19481,335,0.93 [0.69-1.26],0.6460826893620784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19384,238,0.88 [0.61-1.28],0.5117689403573012
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19469,845,0.93 [0.77-1.13],0.4593896038401588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19854,24,0.53 [0.13-2.11],0.3691985279618003
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18179,23,1.73 [0.81-3.70],0.1600947650567594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19196,50,1.26 [0.67-2.39],0.4750564108085515
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19617,214,0.79 [0.53-1.19],0.2595150428688245
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18556,400,0.97 [0.75-1.27],0.850483548256954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18223,67,0.93 [0.48-1.83],0.8386881091697364
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19811,66,0.79 [0.38-1.65],0.5253320643843558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18786,162,0.86 [0.55-1.35],0.5132513291518104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19723,174,1.48 [1.09-2.00],0.0108867121936401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19457,54,0.87 [0.40-1.89],0.7278207779598251
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18208,52,0.76 [0.33-1.74],0.5101131056073847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19481,1325,1.02 [0.88-1.18],0.7860062752435751
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18593,437,1.03 [0.80-1.31],0.8242620195214402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18226,70,0.98 [0.51-1.85],0.9399536451158363
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19790,241,1.29 [0.96-1.72],0.0862821820451033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19449,46,1.06 [0.49-2.28],0.880761828287263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19760,211,1.36 [1.01-1.83],0.0404216980857207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19826,277,0.96 [0.70-1.32],0.7961538121294442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18232,76,0.74 [0.37-1.48],0.392253076592891
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18375,219,1.01 [0.71-1.43],0.9679892628508934
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19821,272,0.93 [0.67-1.30],0.6877310528292466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18361,205,1.06 [0.74-1.54],0.7383688381178978
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19843,98,0.74 [0.40-1.37],0.3421190651083037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17121,71,1.52 [0.92-2.51],0.1055044946776715
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18116,3935,1.05 [0.97-1.14],0.2257605051935734
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16955,2774,1.06 [0.96-1.17],0.2372315295073478
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17115,65,1.36 [0.78-2.38],0.2807403573637321
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17464,120,1.22 [0.79-1.88],0.3645994848792409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17461,117,0.84 [0.49-1.45],0.5293748552879098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19687,53,1.32 [0.71-2.47],0.3796339078853221
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17410,66,0.94 [0.47-1.86],0.8527059230846165
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14903,722,0.89 [0.73-1.10],0.290208859415144
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19760,125,0.42 [0.22-0.78],0.0062654085844051
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17558,214,1.05 [0.73-1.50],0.8077128268874805
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16902,5171,1.12 [1.04-1.20],0.0020485961924704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19008,80,0.68 [0.34-1.38],0.2906603821274783
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17185,135,1.37 [0.93-2.01],0.1145334516646762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17426,376,1.26 [0.99-1.60],0.0610499593699245
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19172,1828,1.17 [1.04-1.31],0.0067208327441218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17363,313,1.24 [0.95-1.61],0.1092050199875516
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17097,47,0.69 [0.27-1.76],0.4380626643649468
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17135,85,0.81 [0.43-1.54],0.5226137973738976
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19596,26,1.49 [0.69-3.22],0.3082920850751838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15368,1187,1.06 [0.91-1.23],0.4446195583881455
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14973,792,1.18 [1.00-1.39],0.0535683663296055
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19750,779,1.15 [0.96-1.37],0.1298866069900315
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14217,36,1.22 [0.57-2.59],0.6055525130969621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14250,69,0.97 [0.51-1.84],0.9196490610568137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17272,222,1.58 [1.22-2.04],0.0005096996152621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14697,516,1.14 [0.92-1.41],0.2387446060781179
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17374,30,0.84 [0.29-2.44],0.7529223189181253
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17774,430,1.15 [0.90-1.46],0.2601217352802099
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17557,213,1.17 [0.84-1.64],0.3514922792723929
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14663,482,1.16 [0.93-1.45],0.1877583493239185
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17105,55,1.37 [0.75-2.50],0.3014125121750529
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17091,41,1.20 [0.55-2.62],0.6391963213589169
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19001,73,0.81 [0.40-1.62],0.5520650906733039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19622,694,1.06 [0.87-1.29],0.5473113385518935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19245,317,1.19 [0.91-1.56],0.2043158830679135
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19798,250,1.45 [1.12-1.87],0.0046473326386348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15723,1542,1.16 [1.03-1.31],0.0178347397685677
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14222,41,0.63 [0.23-1.72],0.3702902755122518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17113,63,1.54 [0.94-2.53],0.0873093612400209
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14230,49,1.37 [0.77-2.45],0.2870671363025768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14217,36,0.95 [0.38-2.35],0.905112356821448
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19083,155,1.06 [0.70-1.62],0.7831073248453466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19057,129,1.16 [0.76-1.77],0.4989245122157629
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19835,69,1.18 [0.65-2.13],0.5814287817072644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18587,1243,1.15 [1.00-1.33],0.0438911085425359
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17104,54,0.74 [0.32-1.73],0.4831269352602342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14216,35,1.57 [0.86-2.84],0.1411313180879745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17853,509,1.24 [1.00-1.52],0.0449852441946877
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15585,1404,1.09 [0.95-1.25],0.2101336948632211
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19612,42,1.76 [1.06-2.93],0.0285850723769615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19851,55,0.81 [0.36-1.79],0.5994372930054777
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17121,71,1.32 [0.77-2.27],0.3150767078943408
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17860,810,1.24 [1.04-1.46],0.0140169529110743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17126,76,1.49 [0.93-2.38],0.0961768562383021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15178,997,1.04 [0.88-1.22],0.6443617702176396
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19000,72,1.11 [0.61-2.03],0.7304952142772476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17087,37,1.91 [1.15-3.18],0.0131275625652946
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17440,96,1.37 [0.88-2.13],0.1575518356479579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17460,410,1.20 [0.94-1.53],0.1379314488946937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19733,163,1.36 [0.98-1.89],0.0656227033717562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17743,399,1.22 [0.96-1.54],0.1074293427907665
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19806,247,1.46 [1.13-1.88],0.0033670437302969
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19851,32,1.31 [0.60-2.84],0.4967043386272437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17176,126,1.45 [1.00-2.12],0.0519014186686909
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16310,468,1.01 [0.79-1.29],0.9639157817117286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17445,395,1.22 [0.96-1.56],0.1077880443771443
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17334,284,1.30 [1.00-1.70],0.052764457270714
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14206,25,1.00 [0.35-2.85],0.9952325156941436
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16054,1873,1.12 [1.00-1.25],0.0508563103477679
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14548,367,1.22 [0.96-1.55],0.1021278791262574
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19705,135,1.31 [0.90-1.90],0.160838873647463
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19801,35,1.60 [0.85-2.99],0.1418562171590831
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18230,35,0.42 [0.13-1.39],0.154285021822947
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14238,57,0.93 [0.44-1.93],0.83726014935978
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17417,73,0.91 [0.47-1.77],0.7890763702013255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14437,256,1.44 [1.12-1.85],0.004084954951057
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17291,241,1.42 [1.08-1.86],0.0119580600309879
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17520,176,1.09 [0.74-1.61],0.6581360360030035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17410,66,1.17 [0.64-2.13],0.6055821126434091
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15807,26,1.28 [0.54-3.05],0.5811314746885735
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19852,33,1.42 [0.70-2.89],0.3277655845405203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17494,444,1.39 [1.13-1.71],0.0017980739749277
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19587,17,2.02 [1.01-4.03],0.045687853961252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18955,1905,1.23 [1.10-1.37],0.0002302430214088
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17138,88,1.16 [0.68-1.98],0.5812515014223387
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17748,404,1.41 [1.14-1.73],0.0013440545327209
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18971,170,1.28 [0.90-1.82],0.1611477063917873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17459,115,1.14 [0.72-1.82],0.5775053475658434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18421,1077,1.29 [1.13-1.48],0.0002329349770393
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18005,661,1.21 [1.00-1.45],0.0474206068313499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17082,32,1.36 [0.62-2.96],0.4388337756287066
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19605,35,0.97 [0.38-2.46],0.954352845966652
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17158,108,1.21 [0.76-1.93],0.4239141655587141
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17066,16,0.34 [0.05-2.08],0.241893670719538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14231,50,1.32 [0.70-2.49],0.3828614355686428
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19133,1482,1.11 [0.98-1.27],0.10846948300986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19463,329,1.13 [0.86-1.49],0.3657657549851544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19257,123,1.05 [0.66-1.67],0.8361207210126003
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18765,1114,1.15 [0.99-1.33],0.0695240833101513
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19670,45,1.31 [0.68-2.52],0.4182691250997303
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19666,284,1.02 [0.75-1.40],0.8868405710213456
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,17523,167,1.20 [0.84-1.73],0.3212059168276888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,17714,63,0.61 [0.27-1.41],0.2483020355055893
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18818,2749,0.93 [0.84-1.03],0.1682591580676358
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17951,4605,0.97 [0.89-1.05],0.4242017952714894
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19695,70,1.28 [0.74-2.20],0.3746361677218439
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16244,175,0.96 [0.64-1.44],0.8562585954926596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17724,288,1.02 [0.75-1.39],0.8993939493925494
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18218,2149,0.94 [0.84-1.06],0.3100237690660741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16266,197,0.94 [0.64-1.38],0.7487144234400614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17416,60,0.86 [0.41-1.80],0.6957386746908986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16168,99,1.28 [0.82-1.98],0.2782281925930348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19858,52,1.09 [0.55-2.19],0.7988675429759797
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19858,41,1.24 [0.61-2.52],0.5481445543544354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19178,1822,1.04 [0.92-1.17],0.5673453843014773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18155,799,1.08 [0.90-1.29],0.3941938539061782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19811,429,1.08 [0.85-1.38],0.5119132557603212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16327,258,0.61 [0.41-0.92],0.0172013250264392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16306,237,0.71 [0.48-1.06],0.0974132556631718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16257,188,0.99 [0.68-1.46],0.9725193274305252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19854,41,1.13 [0.52-2.44],0.7541988882797153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18571,1215,0.99 [0.85-1.15],0.8815827070581682
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17758,322,1.02 [0.76-1.37],0.9026626414079192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19526,144,1.33 [0.92-1.90],0.1253994997479751
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19678,53,1.52 [0.90-2.58],0.1203508527454407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16289,220,0.83 [0.56-1.23],0.3540866413256954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19658,2222,1.06 [0.95-1.18],0.2921165718334334
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17488,52,1.50 [0.87-2.60],0.145513941480137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17761,110,1.02 [0.62-1.69],0.9250460860201536
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19197,63,1.16 [0.62-2.18],0.637152555502176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17604,248,1.14 [0.83-1.55],0.4184141039010268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19568,434,1.15 [0.91-1.46],0.2285777857693655
